- Home
- DNTH vs MUJ Comparison
DNTH vs MUJ Comparison
Compare DNTH & MUJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MUJ
- Stock Information
- Founded
- DNTH 2015
- MUJ 1998
- Country
- DNTH United States
- MUJ United States
- Employees
- DNTH N/A
- MUJ N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MUJ Investment Bankers/Brokers/Service
- Sector
- DNTH Health Care
- MUJ Finance
- Exchange
- DNTH Nasdaq
- MUJ Nasdaq
- Market Cap
- DNTH 670.7M
- MUJ 602.6M
- IPO Year
- DNTH N/A
- MUJ N/A
- Fundamental
- Price
- DNTH $22.29
- MUJ $11.51
- Analyst Decision
- DNTH Strong Buy
- MUJ
- Analyst Count
- DNTH 9
- MUJ 0
- Target Price
- DNTH $46.43
- MUJ N/A
- AVG Volume (30 Days)
- DNTH 245.5K
- MUJ 108.0K
- Earning Date
- DNTH 03-20-2025
- MUJ 01-01-0001
- Dividend Yield
- DNTH N/A
- MUJ 4.36%
- EPS Growth
- DNTH N/A
- MUJ N/A
- EPS
- DNTH N/A
- MUJ N/A
- Revenue
- DNTH $5,366,000.00
- MUJ N/A
- Revenue This Year
- DNTH $100.14
- MUJ N/A
- Revenue Next Year
- DNTH N/A
- MUJ N/A
- P/E Ratio
- DNTH N/A
- MUJ N/A
- Revenue Growth
- DNTH 51.41
- MUJ N/A
- 52 Week Low
- DNTH $18.35
- MUJ $9.74
- 52 Week High
- DNTH $33.77
- MUJ $11.70
- Technical
- Relative Strength Index (RSI)
- DNTH 49.77
- MUJ 60.77
- Support Level
- DNTH $21.28
- MUJ $11.31
- Resistance Level
- DNTH $23.28
- MUJ $11.39
- Average True Range (ATR)
- DNTH 1.75
- MUJ 0.09
- MACD
- DNTH 0.17
- MUJ 0.03
- Stochastic Oscillator
- DNTH 79.92
- MUJ 100.00
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a closed-end management investment company. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund invests in a portfolio of long-term, investment-grade New Jersey municipal obligations.